6-methyladenine has been researched along with Peritoneal Carcinomatosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, KY; Cai, J; Du, S; Guo, JF; Jia, NE; Liu, L; Lv, G; Suo, S; Wang, SH; Wang, WW; Zhang, YF | 1 |
1 other study(ies) available for 6-methyladenine and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
EZH2 Contributes to Anoikis Resistance and Promotes Epithelial Ovarian Cancer Peritoneal Metastasis by Regulating m6A.
Topics: Adenocarcinoma; Animals; Anoikis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Peritoneal Neoplasms | 2023 |